These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 32712319)

  • 1. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
    Fang C; Schmaier AH
    Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic activities of the contact activation system.
    Schmaier AH
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems.
    Schmaier AH
    Front Med (Lausanne); 2016; 3():61. PubMed ID: 27965959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
    Schmaier AH
    J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.
    Stavrou EX; Fang C; Merkulova A; Alhalabi O; Grobe N; Antoniak S; Mackman N; Schmaier AH
    Blood; 2015 Jan; 125(4):710-9. PubMed ID: 25339356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.
    Shariat-Madar Z; Mahdi F; Warnock M; Homeister JW; Srikanth S; Krijanovski Y; Murphey LJ; Jaffa AA; Schmaier AH
    Blood; 2006 Jul; 108(1):192-9. PubMed ID: 16514058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy.
    Manchini MT; Serra AJ; Feliciano Rdos S; Santana ET; Antônio EL; de Tarso Camillo de Carvalho P; Montemor J; Crajoinas RO; Girardi AC; Tucci PJ; Silva JA
    PLoS One; 2014; 9(7):e101270. PubMed ID: 24991808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system.
    Schmaier AH
    Int Immunopharmacol; 2008 Feb; 8(2):161-5. PubMed ID: 18182220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Angiotensin-(1-7) with kinins in the kidney circulation: Role of B
    Mendes EP; Ianzer D; Peruchetti DB; Santos RAS; Vieira MAR
    Peptides; 2024 Sep; 179():171246. PubMed ID: 38821119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
    Scharfstein J; Ramos PIP; Barral-Netto M
    Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
    Schmaier AH
    Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
    Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
    J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and activation of the plasma kallikrein/kinin system: a new interpretation.
    Shariat-Madar Z; Mahdi F; Schmaier AH
    Int Immunopharmacol; 2002 Dec; 2(13-14):1841-9. PubMed ID: 12489798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.
    Su JB
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):319-28. PubMed ID: 23386283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C21 preserves endothelial function in the thoracic aorta from DIO mice: role for AT2, Mas and B2 receptors.
    González-Blázquez R; Alcalá M; Fernández-Alfonso MS; Steckelings UM; Lorenzo MP; Viana M; Boisvert WA; Unger T; Gil-Ortega M; Somoza B
    Clin Sci (Lond); 2021 May; 135(9):1145-1163. PubMed ID: 33899912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
    Ponchon P; Elghozi JL
    Eur J Pharmacol; 1996 Feb; 297(1-2):61-70. PubMed ID: 8851167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade.
    Tschöpe C; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):478-87. PubMed ID: 11904521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
    Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
    Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.